Download PDF
Pneumologie 2000; 54(8): 361-371
DOI: 10.1055/s-2000-6949
EMPFEHLUNGEN
Georg Thieme Verlag Stuttgart · New York

Empfehlungen zur Diagnostik des Bronchialkarzinoms

Deutsche Gesellschaft für PneumologieM. Thomas (federführend), U. Gatzemeier, R. Goerg, W. Matthiessen, H. Morr, N. Schönfeld, D. Ukena, G. Stamatis
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
   Permissions and Reprints

Das Bronchialkarzinom ist mit weitem Abstand die häufigste Krebserkrankung des Mannes, während es bei der Frau in der Häufigkeit die dritte Stelle nach dem Mammakarzinom und nach dem Kolonkarzinom einnimmt. Bei einer geschätzten Inzidenz von 71/100 000 für Männer und 20/100 000 für Frauen sind 1996 in Deutschland ca. 37 000 Menschen am Bronchialkarzinom verstorben [[1]]. Während die Inzidenz bei Männern seit 1980 unverändert ist, hat sie sich bei Frauen in diesem Zeitraum nahezu verdoppelt. Die Inzidenz- und Mortalitätsmuster reflektieren mit einer Latenz von 20 Jahren den inhalativen Tabakkonsum in der Bevölkerung. Weiterhin sind Asbest, Arsen, Nickel, polyzyklische Kohlenwasserstoffe, Chromate und ionisierende Strahlung ätiologisch relevante Karzinogene.

Literatur

  • 1 Statistisches Jahrbuch für die Bundesrepublik Deutschland .Stuttgart: Metzler-Poeschel 1998
  • 2 Fontana R S, Sanderson D R, Taylor W F, Woolner L B, Miller W E, Muhm J R, Uhlenhopp M A. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study.  Am Rev Respir Dis. 1984;  130 561-565
    PubMedGoogle Scholar
  • 3 Frost J K, Ball Jr W C, Levin M L, Tockman M S, Baker R R, Carter D, Egglestone J C, Erozan Y S, Gupta P K, Khouri N F. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study.  Am Rev Respir Dis. 1984;  130 549-554
    PubMedGoogle Scholar
  • 4 Kubik A, Parkin D M, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia.  Int J Cancer. 1990;  45 26-33
    PubMedGoogle Scholar
  • 5 Martini N. Results of Memorial Sloan-Kettering lung project.  Recent Results Cancer Res. 1982;  82 174-178
    PubMedGoogle Scholar
  • 6 Flehinger B, Kimmel M, Polyak T, Melamed M. Screening for lung cancer.  Cancer. 1993;  72 1573-1580
    PubMedGoogle Scholar
  • 7 Strauss G M, Gleason R E, Sugarbaker D J. Screening for lung cancer. Another look; a different view.  Chest. 1997;  111 754-768
    CrossrefPubMedGoogle Scholar
  • 8 Mulshine J L, Scott F. Molecular markers in early cancer detection. New screening tools.  Chest. 1995;  107 (6 suppl) 280-286
    PubMedGoogle Scholar
  • 9 Tockman M S, Erozan Y S, Gupta P, Piantadosi S, Mulshine J L, Ruckdeschel J C. The early detection of second primary lung cancer by sputum immunostaining. LCEWDG investigators: Lung Cancer Early Detection Group.  Chest. 1994;  106 385-390
    PubMedGoogle Scholar
  • 10 Baumgartner R, Huber R M, Schulz H, Stepp H, Rick K, Gamarra F, Leberig A, Roth C. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer.  J Photochem Photobiol. 1996;  B 36 169-174
    PubMedGoogle Scholar
  • 11 Lam S, Kennedy T, Unger M, Miller Y E, Gelmont D, Rusch V, Gipe B, Howard D, LeRiche J C, Coldman A, Gazdar A F. Localization of bronchial epithelial neoplastic lesions by fluorescence bronchoscopy.  Chest. 1998;  113 696-702
    PubMedGoogle Scholar
  • 12 Khanavkar B, Gnudi F, Muti A, Marek W, Müller K M, Atay Z, Topalidis T, Nakhosteen J A. Grundlagen der LIFE-Autofluoreszenzbronchoskopie. Ergebnisse nach 194 Untersuchungen im Vergleich mit Standardverfahren der Früherkennung des Bronchialkarzinoms - Übersicht.  Penumologie. 1998;  52 71-76
    PubMedGoogle Scholar
  • 13 Andersen H A, Prakash U BS. Diagnosis of symptomatic lung cancer.  Semin Respir Med. 1982;  3 165-175
    PubMedGoogle Scholar
  • 14 Cohen M H. Signs and symptoms of bronchogenic carcinoma. In: Strauss MJ (Hrsg): Lung Cancer, Clinical Diagnosis and Treatment. 2nd Ed. New York: Grune and Stratton 1983: 97-111
    Google Scholar
  • 15 Cromartie R S, Park E F, May J E. et al . Carcinoma of the lung: a clinical review.  Ann Thorac Surg. 1980;  30 30-35
    PubMedGoogle Scholar
  • 16 Grippi M A. Clinical aspects of lung cancer.  Semin Roentgenol. 1990;  25 12-24
    PubMedGoogle Scholar
  • 17 Nathanson L, Hall T C. Paraneoplastic Syndromes.  Semin Oncol. 1997;  24,3 265-381
    PubMedGoogle Scholar
  • 18 Ferrigno D, Buccheri G. Clinical applications of serum markers for lung cancer.  Respir Med. 1995;  89 587-597
    PubMedGoogle Scholar
  • 19 Spiro S G. Bronchial tumors. In: Brewis RAL, Corrin B, Geddes DM, Gibson GJ (Hrsg): Respiratory Medicine New York: WB Saunders 1995
    Google Scholar
  • 20 World Health Organization .Histological Typing of Lung and Pleural Tumors, 3nd ed. Geneva: World Health Organization 1999
    Google Scholar
  • 21 Roggli V L, Vollmer R T, Greenberg S D, McGavran M H, Spjut H J, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.  Hum Pathol. 1985;  16 569
    CrossrefPubMedGoogle Scholar
  • 22 Thomas J S, Lamb D, Ashcroft T, Corrin B, Edwards C W, Gibbs A R, Kenyon W E, Stephens R J, Whimster W F. How reliable is the diagnosis of lung cancer using small biopsy specimens? Reports of a UKCCCR Lung Cancer Working Party.  Thorax. 1993;  48 1135-1139
    PubMedGoogle Scholar
  • 23 Leitlinien der Bundesärztekammer zur Qualitätssicherung in der Röntgendiagnostik . Qualitätskriterien röntgenologische Untersuchungen.  Dtsch Ärzteblatt. 1995;  92 A 2272-2285
    PubMedGoogle Scholar
  • 24 Bittner R C, Felix R. Magnetic resonance (MR) imaging of the chest: state-of-the-art.  Europ Resp J. 1998;  11 1392-1404
    PubMedGoogle Scholar
  • 25 Ratto G B, Piancenza G, Frola C, Musante F, Serrano R, Giua R, Salio M, Jacovoni P, Rovida S. Chest wall involvement by lung cancer: computed tomographic detection and results of operation.  Ann Thorac Surg. 1991;  51 182-188
    PubMedGoogle Scholar
  • 26 Padovani B, Mouroux J, Seksik L, Chanalet S, Sedat J, Rotomondo C, Richelme H, Serres J. Chest wall invasion by bronchogenic carcinoma: evaluation with MR-imaging.  Radiology. 1993;  187 33-38
    PubMedGoogle Scholar
  • 27 Martini N, Heelan R, Westcott J, Bains M, McCormack P, Caravelli J, Watson R, Zaman M. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma.  J Thorac Cardiovasc Surg. 1985;  90 639-648
    PubMedGoogle Scholar
  • 28 Laurent F, Drouillard J, Dorcier F, Velly J, Barat J, Grelet P, Martigne C, Tavernier J, Couraud L. Bronchogenic carcinoma staging: CT versus MR imaging. Assessment with surgery.  Eur J Cardiothorac Surg. 1988;  2 31-36
    CrossrefPubMedGoogle Scholar
  • 29 Bülzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, van Kaick G, Müller K M, Voigt-Moykopf I. New aspects in the staging of lung cancer. Prospective validation of the international Union Against Cancer TNM-classification.  Cancer. 1992;  70 1102-1110
    PubMedGoogle Scholar
  • 30 Glazer H S, Duncan-Meyer J, Aronberg D J, Moran J F, Levitt R G, Sagel S S. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation.  Radiology. 1985;  157 191-194
    PubMedGoogle Scholar
  • 31 American Thoracic Society/European Respiratory Society . Pretreatment evaluation of non-small-cell lung cancer.  Am J Respir Crit Care Med. 1997;  156 320-332
    CrossrefPubMedGoogle Scholar
  • 32 Castagno A A, Shuman W P. MR imaging in clinically suspected brachial plexus tumor.  AJR. 1987;  149 1219-1222
    PubMedGoogle Scholar
  • 33 Rapoport S, Blair D N, McCarthy S M, Desser T S, Hammers L W, Sostman H D. Brachial plexus: correlation of MR imaging with CT and pathologic findings.  Radiology. 1988;  167 161-165
    PubMedGoogle Scholar
  • 34 Libshitz H I, McKenna Jr R J, Mountain C F. Mediastinal lymph node size in lung cancer.  AJR. 1984;  143 715-718
    PubMedGoogle Scholar
  • 35 Platt J F, Glazer G M, Orringer M B, Gross B H, Quint L E, Francis I R, Bland P H. Radiologic evaluation of the subcarinal lymph nodes: a comparative study.  AJR. 1988;  151 279-282
    PubMedGoogle Scholar
  • 36 Friedman P J, Feigin D S, Liston S E, Alazraki N P, Haghighi P, Young J A, Peters R M. Sensitivity of chest radiography, computed tomography, and gallium scanning to metastasis of lung carcinoma.  Cancer. 1984;  54 1300-1306
    PubMedGoogle Scholar
  • 37 Frederick H M, Bernhardino M E, Baron M, Colvin R, Mansour K, Miller J. Accuracy of chest computerized tomography in detecting malignant hilar and mediastinal involvement by squamous cell carcinoma of the lung.  Cancer. 1984;  54 2390-2395
    PubMedGoogle Scholar
  • 38 Staples C A, Müller N L, Miller R R, Evans K G, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.  Radiology. 1988;  167 367-372
    CrossrefPubMedGoogle Scholar
  • 39 McLoud T C, Bourgouin P M, Greenberg R W, Kosiuk J P, Templeton P A, Shepard J AO, Moore E H, Wain J C, Mathisen D J, Grillo H C. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.  Radiology. 1992;  182 319-323
    CrossrefPubMedGoogle Scholar
  • 40 McKenna R J, Libshitz H I, Moutain C F. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer.  Chest. 1985;  88 206
    PubMedGoogle Scholar
  • 41 Gross B H, Glazer G M, Orringer M B, Spizarny D L, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.  Radiology. 1988;  166 71-74
    CrossrefPubMedGoogle Scholar
  • 42 The Canadian Lung Oncology Group . Investigation for mediastinal desease in patients with apparently operable lung cancer.  Ann Thorac Surg. 1995;  60 1382-1389
    CrossrefPubMedGoogle Scholar
  • 43 Silvestri G A. Staging strategies for patients with newly diagnosed bronchogenic carcinoma: the importance of the clinical evaluation.  Sem Resp Crit Care Med. 1996;  17 343-348
    PubMedGoogle Scholar
  • 44 Hillers T K, Sauve M D, Guyatt G H. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.  Thorax. 1994;  49 14-19
    PubMedGoogle Scholar
  • 45 Salvatierra A, Baamonde C, Ilamas J M, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma.  Chest. 1990;  97 1052-1058
    CrossrefPubMedGoogle Scholar
  • 46 Colice G, Birkmeyer J, Black W, Littenberg B, Silvestri G. Cost-effectiveness of head CT in patients with lung cancer and no clinical evidence of metastases.  Chest. 1995;  108 1264-1721
    PubMedGoogle Scholar
  • 47 Michel F, Soler M, Imhof E, Perruchoud A P. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.  Thorax. 1991;  46 469-473
    CrossrefPubMedGoogle Scholar
  • 48 Silvestri G A, Littenberg B, Colice G L. The clinical evaluation for detecting metastatic lung cancer: a meta-analysis.  Am J Respir Crit Care Med. 1995;  152 225-230
    PubMedGoogle Scholar
  • 49 Moser E. Skelett-, Knochenmarkszintigraphie oder spezifische Verfahren.  KrankenhausArzt. 1997;  70 435-439
    PubMedGoogle Scholar
  • 50 Reske S N, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher M F. Klinische Wertigkeit der Positronen-Emissions-Tomographie (PET) bei onkologischen Fragestellungen: Ergebnisse einer interdisziplinären Konsensus-Konferenz.  Nuklear Medizin. 1996;  35 42-52
    PubMedGoogle Scholar
  • 51 Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, Scott W, Mailliard J, Lynch W, Bishop J. et al . Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.  Int J Radiat Oncol Biol Phys. 1995;  32 1495-1512
    CrossrefPubMedGoogle Scholar
  • 52 Gould M K, Owens D K. Positron emission tomography for mediastinal staging in non-small cell lunger cancer: A meta-analysis.  Am J Respir Crit Care Med. 1998;  157 A256
    PubMedGoogle Scholar
  • 53 Hughes J MB. 18F-Fluorodeoxyglucose PET scans in lung cancer.  Thorax. 1996;  51 (Suppl 2) 16-22
    PubMedGoogle Scholar
  • 54 Inoue T, Kim E E, Komaki R, Wong F C, Bassa P, Wong W H, Yang D J, Endo K, Podoloff D A. Detecting recurrent or residual lung cancer with FDG-PET.  J Nucl Med. 1995;  36 788-793
    PubMedGoogle Scholar
  • 55 Vansteenkiste J F, Stroobands S G, DeLeyn P R, Dupont P J, Bogaert J, Mases A H, Deneffe G J, Nackaerts K L, Verschakelen J A, Lerut T E, Mortelsmans L A, Demendts M G. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.  J Clin Oncol. 1998;  16 2142-2149
    PubMedGoogle Scholar
  • 56 Stokkel M P, Kwa B M, Pauwels E K. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy.  Br J Clin Pract. 1995;  49 235-238
    PubMedGoogle Scholar
  • 57 Valkema R, Steens J, Cleton F J, Pauwels E KJ. The diagnostic utility of somatostatin receptor scintigraphy in oncology.  J Cancer Res Clin Oncol. 1996;  122 513-532
    CrossrefPubMedGoogle Scholar
  • 58 Rudd R M, Gellert A R, Boldy D A, Studdy P R, Pearson M C, Geddes D M, Sinha G. Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type.  Thorax. 1982;  37 462-465
    PubMedGoogle Scholar
  • 59 Dvale P A, Bode F R, Kini S. Diagnostic accuracy in lung cancer. Comparison of techniques used in association with flexible fiberoptic bronchoscopy.  Chest. 1976;  69 752-757
    PubMedGoogle Scholar
  • 60 Richardson R H, Zavala D C, Jukerkee P K. The use of fiberoptic bronchoscopy and brush biopsy in the diagnosis of suspected pulmonary malignancy.  Am Rev Respir Dis. 1974;  109 63-66
    PubMedGoogle Scholar
  • 61 Schaberg T, Mai J, Thalmann U, Loddenkemper R. Die transbronchiale Lymphknotenpunktion über das Fiberbronchoskop bei pulmonalen Neoplasmen.  Prax Klin Pneumol. 1986;  40 306-311
    PubMedGoogle Scholar
  • 62 Dierkesmann R. The diagnostic yield of bronchoscopy.  Cardiovasc Intervent Radiol. 1991;  14 24-28
    PubMedGoogle Scholar
  • 63 Loddenkemper R, Schaberg T, Mai J, Preussler H, Brandt H J. Bronchial evaluation of peripheral localised lung lesions: accuracy of different biopsy techniques.  Eur J Respir Dis. 1983;  64 (suppl) 461-464
    PubMedGoogle Scholar
  • 64 Arroliga A C, Matthay R A. The role of bronchoscopy in lung cancer.  Clin Chest Med. 1993;  14 87-98
    PubMedGoogle Scholar
  • 65 Schönfeld N, Loddenkemper R. Pleural biopsy and thoracoscopy.  Eur Respir Mon. 1998;  9 135-152
    PubMedGoogle Scholar
  • 66 Loddenkemper R. Thoracoscopy - state of the art.  Eur Respir J. 1998;  11 213-221
    CrossrefPubMedGoogle Scholar
  • 67 Kaiser D, Ennker I C, Hartz C. Video-assisted thoracoscopic surgery - indications, results, complications, and contraindications.  Thorac Cardiovasc Surg. 1993;  41 330-334
    PubMedGoogle Scholar
  • 68 Westcott J L. Percutaneous transthoracic needle biopsy.  Radiology. 1988;  169 593-601
    PubMedGoogle Scholar
  • 69 Jereb M. The usefulness of needle biopsy in chest lesions of different sizes and locations.  Radiology. 1980;  134 13-15
    PubMedGoogle Scholar
  • 70 Seyfer A E, Walsh D S, Graeber G M, Nuno I N, Eliasson A H. Chest wall implantation of lung cancer after thin needle aspiration biopsy.  Ann Thorac Surg. 1989;  48 284-286
    PubMedGoogle Scholar
  • 71 Hix W R, Aaron B L. Needle aspiration in lung cancer. Risk of tumor implantation.  Chest. 1990;  96 1539-1540
    PubMedGoogle Scholar
  • 72 Luke W, Pearson F, Todd T, Patterson G, Cooper J. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.  J Thoracic Cardiovasc Surg. 1986;  91 53-56
    PubMedGoogle Scholar
  • 73 Deutsche Gesellschaft für Pneumologie und Deutsche Gesellschft für Thorax-, Herz- und Gefäßchirurgie . Empfehlungen zur Diagnostic, Stadieneinteilung und operativen Therapie des Bronchialkarzinoms.  Pneumologie. 1994a;  48 262-269
    PubMedGoogle Scholar
  • 74 Kaiser D. Operative Therapie. In: Loddenkemper R (Hrsg): Das Bronchialkarzinom und andere bronchopulmonale Tumoren Stuttgart: Kohlhammer 1998: 94-131
    Google Scholar
  • 75 Choi N C, Carey R W, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.  J Clin Oncol. 1997;  15 712-722
    PubMedGoogle Scholar
  • 76 Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müller M R, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.  J Clin Oncol. 1998;  16 622-634
    PubMedGoogle Scholar
  • 77 Thomas M, Rübe C, Semik M, von Eiff M, Freitag L, Macha H N, Wagner W, Klinke F, Scheld H H, Willich N, Berdel W E, Junker K. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer.  J Clin Oncol. 1999;  17 1185-1193
    PubMedGoogle Scholar
  • 78 Kondo D, Imaizumi M, Abe T, Naruke T, Suemasu K. Endoscopic ultrasound examination for mediastinal lymph node metastases of lung cancer.  Chest. 1990;  98 586-593
    PubMedGoogle Scholar
  • 79 Armstrong P, Reznek R H, Philips R R. Diagnostic imaging of lung cancer.  Eur Respir Mon. 1995;  1; 1 137-187
    PubMedGoogle Scholar
  • 80 Chang K J, Erickson R A, Nguyen P. Endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration of the left adrenal gland.  Gastrointest Endosc. 1996;  44 568-572
    CrossrefPubMedGoogle Scholar
  • 81 Becker H D, Messerschmidt E, Schindelbeck F, Ott S. Endobronchialer Ultraschall.  Pneumologie. 1997;  51 620-629
    PubMedGoogle Scholar
  • 82 Quanjer P H, Tammeling G J, Cotes J E, Pederson O F, Peslin R, Yernault O F. Standardized lung function testing: lung volumes and forced expiratory flows. 1993 update.  Eur Respir J. 1993;  6 4-40
    PubMedGoogle Scholar
  • 83 Bolliger C T, Perruchoud A P. Functional evaluation of the lung resection candidate.  Eur Respir J. 1998;  11 198-212
    CrossrefPubMedGoogle Scholar
  • 84 Crapo R O. Carbon monoxide diffusing capactiy (transfer factor).  Semin Respir Crit Care Med. 1998;  19 335-347
    PubMedGoogle Scholar
  • 85 Deutsche Gesellschaft für Pneumologie . Empfehlungen zur Durchführung und Bewertung von Belastungsuntersuchungen in der Pneumologie.  Pneumologie. 1998;  52 225-232
    PubMedGoogle Scholar
  • 86 Wassermann K, Whipp B. Exercise physiology in health and disease.  Am Rev Respir Dis. 1975;  112 219-249
    PubMedGoogle Scholar
  • 87 Schulz C, Emslander H, Riedel M. Beurteilung der funktionellen Operabilität von Patienten mit Bronchialkarzinom.  Pneumologie. 1999;  53 337-347
    PubMedGoogle Scholar
  • 88 Alberts W M. Pulmonary complications of cancer treatment.  Current Opinion in Oncology. 1997;  9 161-169
    PubMedGoogle Scholar
  • 89 Bolliger C T, Wyser C, Roser H, Stulz P, Solèr M, Perruchoud A P. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications.  Chest. 1995;  108 341-348
    CrossrefPubMedGoogle Scholar
  • 90 Deutsche Gesellschaft für Pneumologie . Empfehlungen zur präoperativen Lungenfunktionsdiagnostik.  Pneumologie. 1994;  48 296-299
    PubMedGoogle Scholar
  • 91 Bolliger C T, Jordan P, Solèr M, Stulz P, Gradel E, Skarvan S, Elsasser S, Gonon M, Wyser C, Tamm M, Perruchoud A P. Exercise capacity as a predictor of postoperative complications in lung resection candidates.  Am J Respir Crit Care Med. 1995b;  151 1472-1480
    CrossrefPubMedGoogle Scholar
  • 92 Mountain C. Revisions in the international system for staging lung cancer.  Chest. 1997;  111 1710-1717
    CrossrefPubMedGoogle Scholar
  • 93 Mountain C, Dresler C. Regional lymphnode classification for lung cancer staging.  Chest. 1997;  111 1718-1723
    CrossrefPubMedGoogle Scholar
  • 94 Pearson F, De Larue N, Ilves R, Todd T, Cooper J. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.  J Thorac Cardiovasc Surg. 1982;  83 1-11
    PubMedGoogle Scholar
  • 95 Martini N, Flehinger B. The role of surgery in N2 lung cancer.  Surg Clin North Am. 1987;  7 1037-1049
    PubMedGoogle Scholar
  • 96 Graziano S. Non-small-cell lung cancer: Clinical value of new biological predictors.  Lung Cancer. 1997;  17 (Suppl 1) S37-S58
    CrossrefPubMedGoogle Scholar
  • 97 Thomas M. Tumorassoziierte Prognoseparameter beim nicht-kleinzelligen Bronchialkarzinom.  Pneumologie. 1997;  51 669-677
    PubMedGoogle Scholar
  • 98 Thomas M, Rübe C, Semik M, von Eiff M, Klinke F, Macha H N, Freitag L, Scheld H H, Willich N, Berdel W E, Junker K. Trimodality therapy in stage III non-small-cell lung cancer: prediction of recurrence by assessment of p185neu .  Eur Respir J. 1999;  13 424-429
    CrossrefPubMedGoogle Scholar

Priv.-Doz. Dr M Thomas

Universitätsklinik Münster Med. Klinik und Poliklinik, Innere Med. A

Albert-Schweitzer-Str. 33 48129 Münster

Email: E-mail: mthomas@uni-muenster.de